| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/26/2013 | CA2674837C Anti-ige vaccines |
| 02/26/2013 | CA2477312C Use of soluble fgl2 as an immunosuppressant |
| 02/26/2013 | CA2430115C Recombinant rsv virus expression systems and vaccines |
| 02/21/2013 | WO2013026033A2 Strains and methods useful for mycotoxins |
| 02/21/2013 | WO2013026025A1 Cyclohexyl azetidine derivatives as jak inhibitors |
| 02/21/2013 | WO2013025834A2 Compositions and methods related to antibodies to staphylococcal protein a |
| 02/21/2013 | WO2013025538A2 Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024895A1 Tricyclic heterocyclic compounds and jak inhibitors |
| 02/21/2013 | WO2013024427A1 Novel urea derivatives as tec kinase inhibitors and uses thereof |
| 02/21/2013 | WO2013024104A1 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo[4,5-c]quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor |
| 02/21/2013 | WO2013024011A1 Indazole compounds, compositions and methods of use |
| 02/21/2013 | WO2013024002A1 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/21/2013 | WO2013023615A1 Use of vanillic acid glycoside derivatives for treating systemic autoimmune disease |
| 02/21/2013 | WO2013023439A1 Salt and polymorph of pyrazolopyrimidinone compound and drug composition, preparation method and use thereof |
| 02/21/2013 | US20130046257 Methods of using agents that modulate claudin expression |
| 02/21/2013 | US20130046005 Treatment of immune disorders using kainate receptor antagonists |
| 02/21/2013 | US20130046004 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 02/21/2013 | US20130045997 Pirfenidone therapy and inducers of of cytochrome p450 |
| 02/21/2013 | US20130045975 Bicyclic heteroaryl inhibitors of pde4 |
| 02/21/2013 | US20130045973 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 02/21/2013 | US20130045963 Cyclohexyl Azetidine Derivatives as JAK Inhibitors |
| 02/21/2013 | US20130045936 Composition comprising an amorphous non-crystalline glass form of roxithromycin |
| 02/21/2013 | US20130045934 Extraction method using ultra fine bubbles and liquid extracts obtained thereof |
| 02/21/2013 | US20130045929 Crystalline forms of the mono-sodium salt of d-isoglutamyl-d-tryptophan |
| 02/21/2013 | US20130045914 Biaryl spiroaminooxazoline analogues as alpha2c adrenergic receptor modulators |
| 02/21/2013 | US20130045520 Double-stranded oligonucleotides |
| 02/21/2013 | US20130045291 Anti-Allergic Composition |
| 02/21/2013 | US20130045267 Methods of using agents that modulate claudin expression |
| 02/21/2013 | US20130045237 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
| 02/21/2013 | US20130045236 Diagnostic and therapeutic uses of soluble fc-epsilon receptor i for ige-mediated disorders |
| 02/21/2013 | US20130045235 Autologous biological cancer vaccine |
| 02/21/2013 | US20130045234 Neutralizing factors as vaccine adjuvants |
| 02/21/2013 | US20130045233 Novel Allergen |
| 02/21/2013 | US20130045232 Mucosal vaccines |
| 02/21/2013 | US20130045231 Immunogenic composition |
| 02/21/2013 | US20130045230 Composition containing hcmv particles |
| 02/21/2013 | US20130045225 Synthetic Antigen Based on the Ligand Domain of the Plasmodium vivax Duffy Binding Protein |
| 02/21/2013 | US20130045224 Immunostimulatory compositions and methods of use thereof |
| 02/21/2013 | US20130045223 Methods and compositions to protect aquatic invertebrates from disease |
| 02/21/2013 | US20130045222 Compositions and methods for enhancing immune responses to vaccines |
| 02/21/2013 | US20130045221 T-cell receptor capable of recognising an antigen from cytomegalovirus |
| 02/21/2013 | US20130045219 Binding proteins, including antibodies, antibody derivatives and antibody fragments, that specifically bind cd154 and uses thereof |
| 02/21/2013 | US20130045218 Fc receptor binding proteins |
| 02/21/2013 | US20130045206 Antibodies directed against the transferrin receptor and uses thereof for immunotherapy of iron-dependent tumours |
| 02/21/2013 | US20130045202 Anti-pd-l1 antibodies and articles of manufacture |
| 02/21/2013 | US20130045201 Methods of using anti-pd-l1 antibodies and their use to enhance t-cell function to treat tumor immunity |
| 02/21/2013 | US20130045200 Methods of using anti-pd-l1 antibodies and their use to treat infection resulting from t-cell dysfunction |
| 02/21/2013 | US20130045199 Antibody Preparations |
| 02/21/2013 | US20130045191 Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| 02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
| 02/21/2013 | US20130045185 Strains and methods useful for mycotoxins |
| 02/21/2013 | US20130045183 Boswellia oil, its fractions and compositions for enhancing brain function |
| 02/21/2013 | US20130045180 Vaccines, immunotherapeutics and methods for using the same |
| 02/21/2013 | US20130045170 Immunity boosting gum |
| 02/21/2013 | CA2845583A1 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors |
| 02/21/2013 | CA2845536A1 Anti-b7-h4 antibodies and their uses |
| 02/21/2013 | CA2845259A1 Compositions and methods related to antibodies to staphylococcal protein a |
| 02/21/2013 | CA2845250A1 Salt and polymorph of pyrazolopyrimidinone compound, and pharmaceutical composition containing the same, preparation method and use thereof |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/21/2013 | CA2843537A1 4-(8-methoxy-1-((1-methoxypropan-2-yl)-2-(tetrahydro-2h-pyran-4-yl)-1 h-imidazo [4,5-c] quinolin-7-yl)-3,5-dimethylisoxazole and its use as bromodomain inhibitor |
| 02/21/2013 | CA2843499A1 Indazole compounds, compositions and methods of use |
| 02/21/2013 | CA2841458A1 Tricyclic heterocyclic compounds and jak inhibitors |
| 02/21/2013 | CA2838784A1 Pyrazolo[3,4-c]pyridine compounds and methods of use |
| 02/20/2013 | EP2559705A2 Anti-activin a antibodies and uses thereof |
| 02/20/2013 | EP2559694A2 Azaindoles useful as inhibitors of Janus kinases |
| 02/20/2013 | EP2559442A1 Method for regulating microrna content in organisms and uses thereof |
| 02/20/2013 | EP2558500A1 Proteins that bind pi16 and uses thereof |
| 02/20/2013 | EP2558498A2 Antibodies that bind human cd27 and uses thereof |
| 02/20/2013 | EP2558487A1 Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of crohn's disease |
| 02/20/2013 | EP2558474A1 2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses |
| 02/20/2013 | EP2558468A1 5, 7-substituted-imidazo [1, 2-c]pyrimidines as inhibitors of jak kinases |
| 02/20/2013 | EP2558127A1 Targeted pyrrolobenzodiazapine conjugates |
| 02/20/2013 | EP2558069A1 Benzonapthyridine compositions and uses thereof |
| 02/20/2013 | CN102939111A Process for preparing an immunoglobulin composition |
| 02/20/2013 | CN102939109A Combination of drugs with protein-binding prodrugs |
| 02/20/2013 | CN102939105A Immunogenic compositions and related methods |
| 02/20/2013 | CN102939087A Novel indazole derivative or salt thereof, manufacturing intermediate therefor, antioxidant using same, and use for an indazole derivative or salt thereof |
| 02/20/2013 | CN102936553A Hawthorn fruit wine and preparation method thereof |
| 02/20/2013 | CN102936250A 稠合双环mTOR抑制剂 Fused bicyclic inhibitors of mTOR |
| 02/20/2013 | CN102935238A Application of yeast M-dsRNA as TLR3 agonist, and yeast M-dsRNA preparation method |
| 02/20/2013 | CN102935220A Medicine for improving sub-health condition of human body |
| 02/20/2013 | CN102935177A Traditional Chinese medicine composition for treating sjogren syndrome as well as preparation method and application thereof |
| 02/20/2013 | CN102935123A Method for extracting flavones from roses |
| 02/20/2013 | CN102935111A Traditional Chinese medicinal composition for enhancing human body immunity and technology for preparing traditional Chinese medicinal composition |
| 02/20/2013 | CN102935102A Method for simultaneously producing honeysuckle flower distillate and various active substances |
| 02/20/2013 | CN102935098A Acute turpinia leaf general flavone ethanol reflux extract, and preparation method and application thereof |
| 02/20/2013 | CN102934743A Chinese herbal medicinal anti-stress powder for weaned piglet transferred group and preparation method |
| 02/20/2013 | CN102293865B Traditional Chinese medicinal wine with functions of nourishing yin, strengthening yang and prolonging life span, and preparation method thereof |
| 02/20/2013 | CN102276745B Franchet groundcherry fruit stem polysaccharide with immunological activity and preparation method thereof |
| 02/20/2013 | CN102114163B Traditional Chinese medicine for treating Henoch-Schonlein purpura nephritis |
| 02/20/2013 | CN101724019B Thymopeptide-5 active esters, medicinal composition containing same and application thereof |
| 02/20/2013 | CN101491601B Externally administrated preparation of superfine traditional Chinese medicine capable of increasing human disease resistance |
| 02/20/2013 | CN101129418B Compound formulation containing collybia albuminosa and green mushroom bacterium |
| 02/19/2013 | US8378108 Apoptosis signal-regulating kinase inhibitors |
| 02/19/2013 | US8378099 Boronic ester and acid compounds, synthesis and uses |
| 02/19/2013 | US8377967 Piperidine derivative |
| 02/19/2013 | US8377945 Small molecule inhibitors of spleen tyrosine kinase (SYK) |
| 02/19/2013 | US8377893 Highly purified antiendotoxin compound |
| 02/19/2013 | US8377885 Depot systems comprising glatiramer or pharmacologically acceptable salt thereof |